Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 12, 2014

Non-melanoma skin cancer: occupational risk from UV light and arsenic exposure

  • Simona Surdu EMAIL logo

Abstract

Non-melanoma skin cancer (NMSC) has a significant impact on public health and health care costs as a result of high morbidity and disfigurement due to the destruction of surrounding tissues. Although the mortality rates of these tumors are low, the high incidence rates determine a considerable number of deaths. NMSC is the most common type of skin cancer, representing about 1/3 of all malignancies diagnosed worldwide each year. The most common NMSC are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Studies on humans and experimental animals indicate that ultraviolet (UV) light and arsenic play important roles in the development of these skin malignancies. Several epidemiological studies have investigated the risk of developing NMSC and the potential link between exposure to sunlight and arsenic in the agricultural and industrial occupational settings. To date, the published literature suggests that there is no apparent skin cancer risk as regards workplace exposure to artificial UV light or arsenic. Concerning UV light from sun exposure at the workplace, most published studies indicated an elevated risk for SCC, but are less conclusive for BCC. Many of these studies are limited by the methodology used in the evaluation of occupational exposure and the lack of adjustment for major confounders. Therefore, further epidemiological studies are required to focus on exposure assessment at the individual level as well as potential interactions with other occupational and non-occupational exposures and individual susceptibility. In doing so, we can better quantify the true risk of skin cancer in exposed workers and inform effective public health prevention programs.


Corresponding author: Dr. Simona Surdu, School of Public Health, University at Albany, State University of New York, 5 University Place, Rensselaer, NY 12144, USA, Phone: +1 518 5252660, Fax: +1 518 5252665, E-mail:

References

1. IARC. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42, Supplement 7. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 1987.Search in Google Scholar

2. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, et al. Listing occupational carcinogens. Environ Health Perspect 2004;112:1447–59.10.1289/ehp.7047Search in Google Scholar

3. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005;26:1657–67.10.1093/carcin/bgi123Search in Google Scholar

4. Franceschi S, Levi F, Randimbison L, La Vecchia C. Site distribution of different types of skin cancer: New aetiological clues. Int J Cancer 1996;67:24–8.10.1002/(SICI)1097-0215(19960703)67:1<24::AID-IJC6>3.0.CO;2-1Search in Google Scholar

5. Epstein JH. Nonmelanoma skin cancer. Compr Ther 1996;22:179–82.Search in Google Scholar

6. Gallagher RP, Bajdik CD, Fincham S, Hill GB, Keefe AR, et al. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 1996;5:419–24.Search in Google Scholar

7. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41–7.10.1046/j.1365-2133.2002.04804.xSearch in Google Scholar

8. EPA. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. Washington, DC: US Environmental Protection Agency, 1988.Search in Google Scholar

9. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995a;131:164–9.10.1001/archderm.131.2.164Search in Google Scholar

10. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995b;131:157–63.10.1001/archderm.131.2.157Search in Google Scholar

11. Couve-Privat S, Bouadjar B, Avril MF, Sarasin A, Daya-Grosjean L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002;62:7186–9.Search in Google Scholar

12. Karagas MR, Cushing GL, Jr., Greenberg ER, Mott LA, Spencer SK, et al. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001;85:683–6.10.1054/bjoc.2001.1931Search in Google Scholar

13. Gasparro FP. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence. Am J Clin Dermatol 2000;1:337–48.10.2165/00128071-200001060-00002Search in Google Scholar

14. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: Review and update on epidemiologic correlations. Skinmed 2004;3:132–9.10.1111/j.1540-9740.2004.02450.xSearch in Google Scholar

15. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8–18.10.1016/S1011-1344(01)00198-1Search in Google Scholar

16. Saraiya M, Glanz K, Briss PA, Nichols P, White C, et al. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. Am J Prev Med 2004;27:422–66.Search in Google Scholar

17. Young AR. Tanning devices-fast track to skin cancer? Pigment Cell Res 2004;17:2–9.10.1046/j.1600-0749.2003.00117.xSearch in Google Scholar

18. IARC. Solar and ultraviolet radiation. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 1992.Search in Google Scholar

19. IARC. Exposure to artificial UV radiation and skin cancer. Lyon, France: International Agency for Research on Cancer, World Health Organization, 2006.Search in Google Scholar

20. IARC. A review of human carcinogens: Radiation. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 2012.Search in Google Scholar

21. ATSDR. Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Public Health Service, 2007.Search in Google Scholar

22. Mitropoulos P, Norman R. Occupational nonsolar risk factors of squamous cell carcinoma of the skin: a population-based case-controlled study. Dermatol Online J 2005;11:5.10.5070/D37B27W1B2Search in Google Scholar

23. Peate W. Occupational skin disease. Am Fam Physician 2002;66:1025–32.Search in Google Scholar

24. Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E. Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies. Radiology 2004;233:313–21.10.1148/radiol.2332031119Search in Google Scholar

25. WHO. INTERSUN, the global UV project: a guide and compendium. Geneva, Switzerland: World Health Organization, 2003a.Search in Google Scholar

26. Lucas R, McMichael T, Smith W, Armstrong B. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation. Geneva, Switzerland: World Health Organization, 2006.Search in Google Scholar

27. WHO. Ultraviolet radiation as a hazard in the workplace. Geneva, Switzerland: World Health Organization, 2003b.Search in Google Scholar

28. Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation exposure among outdoor workers: State of the evidence and recommendations. Environ Health [serial on the Internet]. 2007;6. Available from: http://www.ehjournal.net/content/6/1/22.10.1186/1476-069X-6-22Search in Google Scholar

29. NIOSH. Criteria for a recommended standard: occupational exposure to ultraviolet radiation. Cincinnati, Ohio: National Institute for Occupational Safety and Health, 1972.Search in Google Scholar

30. Suárez B, López-Abente G, Martínez C, Navarro C, Tormo M, et al. Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study. BMC Public Health 2007;7:180.10.1186/1471-2458-7-180Search in Google Scholar

31. WHO. Arsenic in drinking-water. Background document for development of WHO guidelines for drinking-water quality. Geneva, Switzerland: World Health Organization, 2011.Search in Google Scholar

32. EPA. Arsenic, inorganic (CASRN 7440-38-2): carcinogenicity assessment for lifetime exposure. Washington, DC: Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, 1998a.Search in Google Scholar

33. Nordstrom DK. Worldwide occurrences of arsenic in ground water. Science 2002;296:2143–5.10.1126/science.1072375Search in Google Scholar

34. NRC. Arsenic in drinking water. 2001 Update. Washington, DC: U.S. National Research Council, National Academy Press, 2001.Search in Google Scholar

35. WHO. Air quality guidelines, 2nd ed. Arsenic. Copenhagen, Denmark: World Health Organization Regional Office for Europe, 2000.Search in Google Scholar

36. WHO. Arsenic and arsenic compounds, 2nd ed. Geneva, Switzerland: Environmental Health Criteria 224, International Programme on Chemical Safety, World Health Organization, 2001.Search in Google Scholar

37. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicology Lett 2002;133:1–16.10.1016/S0378-4274(02)00084-XSearch in Google Scholar

38. Hughes MF. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 2006;114:1790–6.10.1289/ehp.9058Search in Google Scholar PubMed PubMed Central

39. Pellizzari ED, Clayton CA. Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS). Environ Health Perspect 2006;114:220–7.10.1289/ehp.8104Search in Google Scholar PubMed PubMed Central

40. Tchounwou PB, Patlolla AK, Centeno JA. Invited reviews: carcinogenic and systemic health effects associated with arsenic exposure – a critical review. Toxicol Pathol 2003;31:575–88.10.1080/01926230390242007Search in Google Scholar PubMed

41. Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 2006;114: 1193–8.10.1289/ehp.9008Search in Google Scholar PubMed PubMed Central

42. Chan CP, Huff J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcino & Ecotox Revs 1997;C15:83–122.10.1080/10590509709373492Search in Google Scholar

43. EPA. Health assessment document for inorganic arsenic. Research Triangle Park, NC: U.S. Environmental Protection Agency, 1984.Search in Google Scholar

44. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008;21:28–44.10.1021/tx700198aSearch in Google Scholar PubMed PubMed Central

45. EPA. Locating and estimating air emissions from sources of arsenic and arsenic compounds. Research Triangle Park, NC: U.S. Environmental Protection Agency, 1998b.Search in Google Scholar

46. EPA. Carcinogenicity assessment for lifetime exposure to arsenic. Cincinnati, OH: U.S. Environmental Protection Agency, 1994.Search in Google Scholar

47. WHO. Guidelines for drinking water quality. Recommendations, 3rd ed. Geneva, Switzerland: World Health Organization, 2006.Search in Google Scholar

48. WHO. Guidelines for drinking water quality. Recommendations, 2nd ed. Geneva, Switzerland: World Health Organization, 1998.Search in Google Scholar

49. Bauer A, Diepgen TL, Schmitt J. Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol 2011;165:612–25.10.1111/j.1365-2133.2011.10425.xSearch in Google Scholar PubMed

50. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour study group. Am J Epidemiol 1996;144:1034–40.Search in Google Scholar

51. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990;46:356–61.10.1002/ijc.2910460303Search in Google Scholar PubMed

52. Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482–8.10.1002/ijc.2910600410Search in Google Scholar PubMed

53. Lichte V, Dennenmoser B, Dietz K, Hafner HM, Schlagenhauff B, et al. Professional risk for skin cancer development in male mountain guides – a cross-sectional study. J Eur Acad Dermatol Venereol 2010;24:797–804.10.1111/j.1468-3083.2009.03528.xSearch in Google Scholar PubMed

54. Kenborg L, Jorgensen AD, Budtz-Jorgensen E, Knudsen LE, Hansen J. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a population-based case-control study. Cancer Causes Control 2010;21:1347–55.10.1007/s10552-010-9562-1Search in Google Scholar PubMed

55. Lock-Andersen J, Drzewiecki KT, Wulf HC. The measurement of constitutive and facultative skin pigmentation and estimation of sun exposure in Caucasians with basal cell carcinoma and cutaneous malignant melanoma. Br J Dermatol 1998;139:610–7.10.1046/j.1365-2133.1998.02456.xSearch in Google Scholar PubMed

56. Milan T, Verkasalo PK, Kaprio J, Koskenvuo M. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 2003;149:115–23.10.1046/j.1365-2133.2003.05352.xSearch in Google Scholar PubMed

57. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999;135:781–6.10.1001/archderm.135.7.781Search in Google Scholar PubMed

58. Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H, et al. The multicentre south European study ’Helios’. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996;73:1447–54.10.1038/bjc.1996.275Search in Google Scholar PubMed PubMed Central

59. Seidler A, Husmann G, Nubling M, Hammer GP, Schmidtmann I, Blettner M, et al. UV-exponierte berufe und hauttumoren: berufsbezogene auswertung von daten des krebsregisters Rheinland-Pfalz. Zbl Arbeitsmed 2006;56:78–90.Search in Google Scholar

60. Radespiel-Troger M, Meyer M, Pfahlberg A, Lausen B, Uter W, et al. Outdoor work and skin cancer incidence: a registry-based study in Bavaria. Int Arch Occup Environ Health 2009;82:357–63.10.1007/s00420-008-0342-0Search in Google Scholar PubMed

61. Walther U, Kron M, Sander S, Sebastian G, Sander R, et al. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170–8.10.1111/j.1365-2133.2004.06030.xSearch in Google Scholar PubMed

62. Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, et al. Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European study. PLoS ONE 2013a;8:e62359.10.1371/journal.pone.0062359Search in Google Scholar PubMed PubMed Central

63. Tobia L, Fanelli C, Bianchi S, Paglione M, Diana S, et al. [Professional exposure to natural ultraviolet radiation: risk assessment and management and preventing strategies]. G Ital Med Lav Ergon 2007;29:422–4.Search in Google Scholar

64. Pelucchi C, Di Landro A, Naldi L, La Vecchia C. Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol 2007;127:935–44.10.1038/sj.jid.5700598Search in Google Scholar PubMed

65. Gafa L, Filippazzo MG, Tumino R, Dardanoni G, Lanzarone F, et al. Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control 1991;2:395–9.10.1007/BF00054300Search in Google Scholar PubMed

66. Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162–8.10.1001/archderm.137.9.1162Search in Google Scholar PubMed

67. Rosso S, Joris F, Zanetti R. Risk of basal and squamous cell carcinomas of the skin in Sion, Switzerland: a case-control study. Tumori 1999;85:435–42.10.1177/030089169908500603Search in Google Scholar

68. Lear JT, Tan BB, Smith AG, Bowers W, Jones PW, et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997;90:371–4.10.1177/014107689709000704Search in Google Scholar PubMed PubMed Central

69. Vlajinac HD, Adanja BJ, Lazar ZF, Bogavac AN, Bjekic MD, et al. Risk factors for basal cell carcinoma. Acta Oncol 2000;39:611–6.10.1080/028418600750013294Search in Google Scholar

70. Zanetti R, Rosso S, Martinez C, Nieto A, Miranda A, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-control study. Br J Cancer 2006;94:743–51.10.1038/sj.bjc.6602982Search in Google Scholar

71. Maia M, Proenca NG, de Moraes JC. Risk factors for basal cell carcinoma: a case–control study. Rev Saude Publica 1995;29:27–37.10.1590/S0034-89101995000100006Search in Google Scholar

72. Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, et al. Occupation and keratinocyte cancer risk: a population- based case-control study. Cancer Causes Control 2007;18: 895–908.10.1007/s10552-007-9034-4Search in Google Scholar

73. Hogan DJ, To T, Gran L, Wong D, Lane PR. Risk factors for basal cell carcinoma. Int J Dermatol 1989;28:591–4.10.1111/j.1365-4362.1989.tb02534.xSearch in Google Scholar

74. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 1989;150:475–8.10.5694/j.1326-5377.1989.tb136588.xSearch in Google Scholar

75. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, et al. Sunlight and non-Hodgkin’s lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641–5.10.1002/(SICI)1097-0215(19990301)80:5<641::AID-IJC1>3.0.CO;2-ZSearch in Google Scholar

76. Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 2011;164:291–307.10.1111/j.1365-2133.2010.10118.xSearch in Google Scholar

77. Pukkala E, Saarni H. Cancer incidence among Finnish seafarers, 1967–92. Cancer Causes Control 1996;7:231–9.10.1007/BF00051299Search in Google Scholar

78. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003;139:890–4.10.1001/archderm.139.7.890Search in Google Scholar

79. Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, Zanetti R, Rosso S, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer 2003;88:1702–7.10.1038/sj.bjc.6600975Search in Google Scholar

80. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12:552–7.10.1097/00001648-200109000-00015Search in Google Scholar

81. Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin. a case-control study in the Montreal region. Cancer 1985;55:907–11.10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO;2-5Search in Google Scholar

82. Hogan DJ, Lane PR, Gran L, Wong D. Risk factors for squamous cell carcinoma of the skin in Saskatchewan, Canada. J Dermatol Sci 1990;1:97–101.10.1016/0923-1811(90)90222-YSearch in Google Scholar

83. Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, et al. Occupational exposure to arsenic and risk of non-melanoma skin cancer in a multinational European study. Int J Cancer 2013b;133:2182–91.10.1002/ijc.28216Search in Google Scholar

84. Gallagher RP, Lee TK. Adverse effects of ultraviolet radiation: a brief review. Prog Biophys Mol Biol 2006;92:119–31.10.1016/j.pbiomolbio.2006.02.011Search in Google Scholar

85. Kütting B, Drexler H. UV-induced skin cancer at workplace and evidence-based prevention. Int Arch Occup Environ Health 2010;83:843–54.10.1007/s00420-010-0532-4Search in Google Scholar

86. Smedley PL, Kinniburgh DG. A review of the source, behaviour and distribution of arsenic in natural waters. Applied Geochemistry 2002;17:517–68.10.1016/S0883-2927(02)00018-5Search in Google Scholar

87. Gawkrodger DJ. Occupational skin cancers. Occup Med (Lond) 2004;54:458–63.10.1093/occmed/kqh098Search in Google Scholar

Received: 2014-5-13
Accepted: 2014-8-21
Published Online: 2014-9-12
Published in Print: 2014-8-1

©2014 by De Gruyter

Downloaded on 2.6.2023 from https://www.degruyter.com/document/doi/10.1515/reveh-2014-0040/html
Scroll to top button